Back to All Events

Join Aivo Biosciences at the ‘Innovation in Psychosis Therapeutics Summit’ for a panel discussion on the complexities of muscarinic agonists (Boston, MA, June 9-11, 2025)


Our CEO Harri Järveläinen will join as an expert speaker on the panel ‘Advances in the Development of Muscarinic Agonists - Learnings from Clinical Trials, Addressing Biology & Subtype Selectivity’. More information: https://ter.li/ud7xr2

Previous
January 1

Aivo Biosciences, Inc. to Participate in Biotech Showcase During JPM Healthcare Conference Week